| IT Investor Alert: Gartner, Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Management Allegedly Inflated Growth Projections: Levi & Korsinsky |
Globe Newswire |
04/27 |
19:47 |
| Qfin Holdings Releases 2025 ESG Report |
Globe Newswire |
04/27 |
19:30 |
| Qfin Holdings Filed 2025 Annual Report on Form 20-F |
Globe Newswire |
04/27 |
19:00 |
| MINILUXE REPORTS FULL-YEAR FINANCIAL RESULTS FOR YEAR ENDED DECEMBER 28, 2025 |
Globe Newswire |
04/27 |
18:52 |
| NOV Reports First Quarter 2026 Earnings |
Globe Newswire |
04/27 |
17:45 |
| BW Investor Alert: Babcock & Wilcox Enterprises Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Company Allegedly Overstated Pipeline Metrics: Levi & Korsinsky |
Globe Newswire |
04/27 |
17:42 |
| Heron Therapeutics to Report First Quarter 2026 Financial Results on Monday, May 11, 2026 |
Globe Newswire |
04/27 |
17:30 |
| SMCI Investor Alert: Super Micro Computer Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Bypassing Export Controls Illegally: Levi & Korsinsky |
Globe Newswire |
04/27 |
17:25 |
| Taysha Gene Therapies to Present New Preclinical Data Supporting Construct Design of TSHA-102 for Rett Syndrome at the ASGCT 2026 Annual Meeting |
Globe Newswire |
04/27 |
17:21 |
| TCOM Investor Alert: Trip.com Group Limited Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Misleading on Regulatory Exposure: Levi & Korsinsky |
Globe Newswire |
04/27 |
17:20 |
| Lexeo Therapeutics Announces Multiple Presentations at the 29th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting |
Globe Newswire |
04/27 |
17:15 |
| Crinetics Pharmaceuticals Announces the European Commission Approval of PALSONIFY® (Paltusotine) for the Treatment of Acromegaly in Adults |
Globe Newswire |
04/27 |
17:13 |
| Brown & Brown, Inc. announces first quarter 2026 results, including total revenues of $1.9 billion, an increase of 35.4%; flat Organic Revenue; growth of Organic Revenue with Contingents of 2.2%; diluted net income per share of $1.06; Diluted Net Income Per Share - Adjusted of $1.39; and a quarterly dividend of $0.165 per share |
Globe Newswire |
04/27 |
17:03 |
| ElevateBio to Present Nine Abstracts Showcasing Advancements Across its Gene Editing Platform at the American Society of Gene and Cell Therapy (ASGCT) 29th Annual Meeting |
Globe Newswire |
04/27 |
17:00 |
| Arbor Biotechnologies to Present Expansion of CNS Editing Platform Capabilities at the American Society of Gene and Cell Therapy (ASGCT) 29th Annual Meeting |
Globe Newswire |
04/27 |
17:00 |
| Auddia Announces Closing of $12 Million Public Offering |
Globe Newswire |
04/27 |
16:55 |
| AI Tools Give PR Teams Measurable Citation Data for First Time |
Globe Newswire |
04/27 |
16:45 |
| Voyager IV-Delivered CNS Gene Therapies Featured in Multiple Presentations at ASGCT 2026, Including Late Breaker on Tau-Targeted VY1706 for Alzheimer’s Disease |
Globe Newswire |
04/27 |
16:31 |
| Editas Medicine to Present New Preclinical Data Demonstrating Progress of EDIT-401 as Potential Treatment for Hyperlipidemia at Upcoming Scientific Conferences |
Globe Newswire |
04/27 |
16:31 |
| Sana Biotechnology Announces Oral Presentation Highlighting Preclinical Data from in vivo CAR T SG293 at the American Society of Gene & Cell Therapy (ASGCT) 2026 Annual Meeting |
Globe Newswire |
04/27 |
16:30 |
| Addition Therapeutics Announces Multiple Oral and Poster Presentations at the American Society of Gene & Cell Therapy (ASGCT) 29th Annual Meeting |
Globe Newswire |
04/27 |
16:30 |
| Rgenta Therapeutics Announces Two Oral Presentations Highlighting Proprietary RSwitch Technology at the American Society of Gene and Cell Therapy (ASGCT) 2026 Annual Meeting |
Globe Newswire |
04/27 |
16:30 |
| Umoja Biopharma Announces Unveiling of UB-VV500 in Upcoming Poster Presentation at the American Society of Gene & Cell Therapy Annual Meeting |
Globe Newswire |
04/27 |
16:30 |
| Global Compression Garments and Stockings Market Size/Share Worth USD 5.10 Billion by 2035 at a 4.8% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis) |
Globe Newswire |
04/27 |
16:30 |
| CVRx to Report First Quarter 2026 Financial and Operating Results and Host Conference Call on May 11, 2026 |
Globe Newswire |
04/27 |
16:30 |
